Skip to main content
Va. biotech Cavion acquired by Jazz Pharmaceuticals
8/14/2019

Jazz Pharmaceuticals has acquired Cavion as part of its expansion plans in Philadelphia. The deal will mean an upfront payment of $52.5 million plus additional payments worth up to $260 million upon completion of specific regulatory and commercial milestones that were not disclosed.

Full Story: